{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:47:18Z","timestamp":1786985238083,"version":"build-2736575974"},"reference-count":140,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,13]],"date-time":"2021-12-13T00:00:00Z","timestamp":1639353600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001786","name":"University of Adelaide","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001786","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.biopha.2021.112541","type":"journal-article","created":{"date-parts":[[2021,12,22]],"date-time":"2021-12-22T06:59:49Z","timestamp":1640156389000},"page":"112541","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"special_numbering":"C","title":["The potential use of folate and its derivatives in treating psychiatric disorders: A systematic review"],"prefix":"10.1016","volume":"146","author":[{"given":"Nelson Siu Kei","family":"Lam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin Xin","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuegang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirette","family":"Saad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James CG","family":"Doery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert C.","family":"Griffin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cherrie","family":"Galletly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.biopha.2021.112541_bib1","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1038\/nbt.1685","article-title":"Epigenetic modifications and human disease","volume":"28","author":"Portela","year":"2010","journal-title":"Nat. Biotechnol."},{"issue":"5637","key":"10.1016\/j.biopha.2021.112541_bib2","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1126\/science.1085515","article-title":"A perspective on enzyme catalysis","volume":"301","author":"Benkovic","year":"2003","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.biopha.2021.112541_bib3","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1038\/s41467-019-08833-7","article-title":"Design strategy for serine hydroxymethyltransferase probes based on retro-aldol-type reaction","volume":"10","author":"Nonaka","year":"2019","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.biopha.2021.112541_bib4","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1084\/jem.20181965","article-title":"Toward a better understanding of folate metabolism in health and disease","volume":"216","author":"Zheng","year":"2018","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.biopha.2021.112541_bib5","unstructured":"Office of Dietary Supplements National Institutes of Health OoDSNIoH. Vitamin B12 Fact Sheet for Health Professionals 2020 [updated March 30, 2020. \u3008https:\/\/ods.od.nih.gov\/factsheets\/vitamin%20B12-HealthProfessional\/\u3009."},{"key":"10.1016\/j.biopha.2021.112541_bib6","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.copbio.2017.01.006","article-title":"Folate nutrition and blood-brain barrier dysfunction","volume":"44","author":"Stover","year":"2017","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.biopha.2021.112541_bib7","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.biochi.2016.02.012","article-title":"The metabolic basis for developmental disorders due to defective folate transport","volume":"126","author":"Desai","year":"2016","journal-title":"Biochimie"},{"issue":"5","key":"10.1016\/j.biopha.2021.112541_bib8","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1038\/sj.bjp.0705446","article-title":"Pharmacokinetic study on the utilisation of 5-methyltetrahydrofolate and folic acid in patients with coronary artery disease","volume":"141","author":"Willems","year":"2004","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.biopha.2021.112541_bib9","unstructured":"Food Standards Australia New Zealand FSANZ. L-5-METHYLTETRAHYDROFOLATE, CALCIUM AS A PERMITTED VITAMIN FORM OF FOLATE 2008. \u3008https:\/\/www.foodstandards.gov.au\/code\/applications\/documents\/A566%20L-Methylfolat%20FAR%20FINAL.pdf\u3009."},{"key":"10.1016\/j.biopha.2021.112541_bib10","article-title":"Blood-brain barrier regulation in psychiatric disorders","volume":"726","author":"Kealy","year":"2018","journal-title":"Neurosci. Lett."},{"issue":"10","key":"10.1016\/j.biopha.2021.112541_bib11","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1177\/0004867418796955","article-title":"Leaky brain in neurological and psychiatric disorders: drivers and consequences","volume":"52","author":"Morris","year":"2018","journal-title":"Aust. N. Z. J. Psychiatry"},{"issue":"10","key":"10.1016\/j.biopha.2021.112541_bib12","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1093\/annonc\/mdv250","article-title":"Targeting the folate receptor: diagnostic and therapeutic approaches to personalize cancer treatments","volume":"26","author":"Ledermann","year":"2015","journal-title":"Ann. Oncol. Off. J. Eur. Soc. Med. Oncol."},{"issue":"5","key":"10.1016\/j.biopha.2021.112541_bib13","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.tips.2020.02.004","article-title":"Clinical implications of folate transport in the central nervous system","volume":"41","author":"Alam","year":"2020","journal-title":"Trends Pharmacol. Sci."},{"issue":"35","key":"10.1016\/j.biopha.2021.112541_bib14","doi-asserted-by":"crossref","first-page":"17531","DOI":"10.1073\/pnas.1907077116","article-title":"Upregulation of reduced folate carrier by vitamin D enhances brain folate uptake in mice lacking folate receptor alpha","volume":"116","author":"Alam","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"11","key":"10.1016\/j.biopha.2021.112541_bib15","doi-asserted-by":"crossref","first-page":"3848","DOI":"10.1021\/acs.molpharmaceut.7b00572","article-title":"Regulation of reduced folate carrier (RFC) by vitamin D receptor at the blood-brain barrier","volume":"14","author":"Alam","year":"2017","journal-title":"Mol. Pharm."},{"issue":"7","key":"10.1016\/j.biopha.2021.112541_bib16","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.3390\/ijms20071632","article-title":"Age-associated changes in the immune system and blood\u2212brain barrier functions","volume":"20","author":"Erickson","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2021.112541_bib17","doi-asserted-by":"crossref","first-page":"5240127","DOI":"10.1155\/2016\/5240127","article-title":"Folic acid is able to polarize the inflammatory response in LPS activated microglia by regulating multiple signaling pathways","volume":"2016","author":"Cianciulli","year":"2016","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.biopha.2021.112541_bib18","doi-asserted-by":"crossref","first-page":"362","DOI":"10.3389\/fncel.2014.00362","article-title":"The impact of microglial activation on blood-brain barrier in brain diseases","volume":"8","author":"da Fonseca","year":"2014","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.biopha.2021.112541_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.mvr.2021.104193","article-title":"Folic acid alleviates the blood brain barrier permeability and oxidative stress and prevents cognitive decline in sepsis-surviving rats","volume":"137","author":"Novochadlo","year":"2021","journal-title":"Microvasc. Res."},{"issue":"2","key":"10.1016\/j.biopha.2021.112541_bib20","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1007\/s12031-013-0122-5","article-title":"Nutri-epigenetics ameliorates blood-brain barrier damage and neurodegeneration in hyperhomocysteinemia: role of folic acid","volume":"52","author":"Kalani","year":"2014","journal-title":"J. Mol. Neurosci. MN"},{"issue":"3","key":"10.1016\/j.biopha.2021.112541_bib21","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1093\/jn\/135.3.544","article-title":"Folic acid supplementation can reduce the endothelial damage in rat brain microvasculature due to hyperhomocysteinemia","volume":"135","author":"Lee","year":"2005","journal-title":"J. Nutr."},{"issue":"3","key":"10.1016\/j.biopha.2021.112541_bib22","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1159\/000071002","article-title":"Vitamin B12-B6-folate treatment improves blood-brain barrier function in patients with hyperhomocysteinaemia and mild cognitive impairment","volume":"16","author":"Lehmann","year":"2003","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"10.1016\/j.biopha.2021.112541_bib23","first-page":"91","article-title":"CSF 5-methyltetrahydrofolate serial monitoring to guide treatment of congenital folate malabsorption due to proton-coupled folate transporter (PCFT) deficiency","volume":"24","author":"Torres","year":"2015","journal-title":"JIMD Rep."},{"issue":"24","key":"10.1016\/j.biopha.2021.112541_bib24","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1212\/WNL.0000000000002766","article-title":"CSF concentrations of 5-methyltetrahydrofolate in a cohort of young children with autism","volume":"86","author":"Shoffner","year":"2016","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.biopha.2021.112541_bib25","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/bdra.23517","article-title":"Levels of folate receptor autoantibodies in maternal and cord blood and risk of neural tube defects in a Chinese population","volume":"106","author":"Yang","year":"2016","journal-title":"Birth Defects Res. Part A Clin. Mol. Teratol."},{"issue":"35","key":"10.1016\/j.biopha.2021.112541_bib26","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000001367","article-title":"Analysis of MTR and MTRR polymorphisms for neural tube defects risk association","volume":"94","author":"Wang","year":"2015","journal-title":"Medicine"},{"issue":"12","key":"10.1016\/j.biopha.2021.112541_bib27","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1007\/s00109-006-0093-x","article-title":"The methionine synthase reductase 66A>G polymorphism is a maternal risk factor for spina bifida","volume":"84","author":"van der Linden","year":"2006","journal-title":"J. Mol. Med."},{"issue":"3","key":"10.1016\/j.biopha.2021.112541_bib28","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1086\/303055","article-title":"Polymorphisms in genes involved in folate metabolism as maternal risk factors for Down syndrome","volume":"67","author":"Hobbs","year":"2000","journal-title":"Am. J. Hum. Genet."},{"issue":"1","key":"10.1016\/j.biopha.2021.112541_bib29","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jpeds.2007.05.047","article-title":"Folate pathway genetic polymorphisms are related to attention disorders in childhood leukemia survivors","volume":"152","author":"Krull","year":"2008","journal-title":"J. Pediatr."},{"issue":"7","key":"10.1016\/j.biopha.2021.112541_bib30","doi-asserted-by":"crossref","first-page":"523","DOI":"10.7150\/ijms.8.523","article-title":"Methylenetetrahydrofolate reductase gene polymorphisms in children with attention deficit hyperactivity disorder","volume":"8","author":"Gokcen","year":"2011","journal-title":"Int. J. Med. Sci."},{"issue":"6","key":"10.1016\/j.biopha.2021.112541_bib31","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1002\/ajmg.b.31094","article-title":"A functional polymorphism in the reduced folate carrier gene and DNA hypomethylation in mothers of children with autism","volume":"153b","author":"James","year":"2010","journal-title":"Am. J. Med. Genet. Part B Neuropsychiatr. Genet. Off. Publ. Int. Soc. Psychiatr. Genet."},{"issue":"6","key":"10.1016\/j.biopha.2021.112541_bib32","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1001\/jama.2012.155925","article-title":"Association between maternal use of folic acid supplements and risk of autism spectrum disorders in children","volume":"309","author":"Sur\u00e9n","year":"2013","journal-title":"Jama"},{"issue":"2","key":"10.1016\/j.biopha.2021.112541_bib33","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/mp.2017.41","article-title":"Biochemical, physiological and clinical effects of l-methylfolate in schizophrenia: a randomized controlled trial","volume":"23","author":"Roffman","year":"2018","journal-title":"Mol. Psychiatry"},{"issue":"4","key":"10.1016\/j.biopha.2021.112541_bib34","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.jpsychires.2004.01.003","article-title":"Homocysteine levels in newly admitted schizophrenic patients","volume":"38","author":"Applebaum","year":"2004","journal-title":"J. Psychiatr. Res."},{"issue":"11","key":"10.1016\/j.biopha.2021.112541_bib35","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.3390\/nu9111206","article-title":"Association between duration of folic acid supplementation during pregnancy and risk of postpartum depression","volume":"9","author":"Yan","year":"2017","journal-title":"Nutrients"},{"key":"10.1016\/j.biopha.2021.112541_bib36","first-page":"1","article-title":"Good, better, best: clinical scenarios for the use of L-methylfolate in patients with MDD","volume":"25","author":"Jain","year":"2019","journal-title":"CNS Spectr."},{"key":"10.1016\/j.biopha.2021.112541_bib37","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.jad.2016.09.053","article-title":"L-Methylfolate for bipolar I depressive episodes: an open trial proof-of-concept registry","volume":"207","author":"Nierenberg","year":"2017","journal-title":"J. Affect. Disord."},{"issue":"7","key":"10.1016\/j.biopha.2021.112541_bib38","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1080\/1354750X.2018.1458152","article-title":"High prevalence of serum folate receptor autoantibodies in children with autism spectrum disorders","volume":"23","author":"Zhou","year":"2018","journal-title":"Biomarkers"},{"issue":"1","key":"10.1016\/j.biopha.2021.112541_bib39","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/s41398-018-0276-6","article-title":"Methylenetetrahydrofolate reductase and psychiatric diseases","volume":"8","author":"Wan","year":"2018","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.biopha.2021.112541_bib40","unstructured":"National Center for Biotechnology Information NCfBi. FOLH1 folate hydrolase 1 [Homo sapiens (human)], 2020."},{"issue":"3","key":"10.1016\/j.biopha.2021.112541_bib41","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.ajhg.2009.08.005","article-title":"Folate receptor alpha defect causes cerebral folate transport deficiency: a treatable neurodegenerative disorder associated with disturbed myelin metabolism","volume":"85","author":"Steinfeld","year":"2009","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.biopha.2021.112541_bib42","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3390\/nu11102353","article-title":"Renal reabsorption of folates: pharmacological and toxicological snapshots","volume":"11","author":"Samodelov","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.biopha.2021.112541_bib43","doi-asserted-by":"crossref","first-page":"343","DOI":"10.3389\/fnbeh.2014.00343","article-title":"Homocysteine levels in schizophrenia and affective disorders-focus on cognition","volume":"8","author":"Moustafa","year":"2014","journal-title":"Front. Behav. Neurosci."},{"issue":"5","key":"10.1016\/j.biopha.2021.112541_bib44","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1002\/jnr.10416","article-title":"Multiple aspects of homocysteine neurotoxicity: glutamate excitotoxicity, kinase hyperactivation and DNA damage","volume":"70","author":"Ho","year":"2002","journal-title":"J. Neurosci. Res."},{"issue":"8","key":"10.1016\/j.biopha.2021.112541_bib45","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1097\/WNR.0b013e328346bf85","article-title":"Homocysteine effects on brain volumes mapped in 732 elderly individuals","volume":"22","author":"Rajagopalan","year":"2011","journal-title":"Neuroreport"},{"issue":"1","key":"10.1016\/j.biopha.2021.112541_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejmg.2014.10.004","article-title":"Methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism: epidemiology, metabolism and the associated diseases","volume":"58","author":"Liew","year":"2015","journal-title":"Eur. J. Med. Genet."},{"issue":"5","key":"10.1016\/j.biopha.2021.112541_bib47","first-page":"2571","article-title":"MTHFR A1298C and C677T gene polymorphisms and susceptibility to chronic myeloid leukemia in Egypt","volume":"7","author":"Aly","year":"2014","journal-title":"Int. J. Clin. Exp. Pathol."},{"issue":"8","key":"10.1016\/j.biopha.2021.112541_bib48","doi-asserted-by":"crossref","first-page":"649","DOI":"10.2217\/bmm-2018-0392","article-title":"Ethnogeographic prevalence and implications of the 677C>T and 1298A>C MTHFR polymorphisms in US primary care populations","volume":"13","author":"Graydon","year":"2019","journal-title":"Biomark. Med."},{"issue":"7571","key":"10.1016\/j.biopha.2021.112541_bib49","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/nature15393","article-title":"A global reference for human genetic variation","volume":"526","author":"Genomes Project","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2021.112541_bib50","first-page":"237","article-title":"MTHFR genetic testing: controversy and clinical implications","volume":"45","author":"Long","year":"2016","journal-title":"Aust. Fam. Physician"},{"issue":"2","key":"10.1016\/j.biopha.2021.112541_bib51","doi-asserted-by":"crossref","first-page":"145","DOI":"10.2165\/00003495-198530020-00003","article-title":"Drugs and folate metabolism","volume":"30","author":"Lambie","year":"1985","journal-title":"Drugs"},{"issue":"20","key":"10.1016\/j.biopha.2021.112541_bib52","doi-asserted-by":"crossref","first-page":"4996","DOI":"10.3390\/ijms20204996","article-title":"Folic acid antagonists: antimicrobial and immunomodulating mechanisms and applications","volume":"20","author":"Fern\u00e1ndez-Villa","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.biopha.2021.112541_bib53","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/S2215-0366(16)30167-5","article-title":"Does folic acid interfere with lamotrigine?","volume":"3","author":"Mischoulon","year":"2016","journal-title":"Lancet Psychiatry"},{"issue":"4","key":"10.1016\/j.biopha.2021.112541_bib54","doi-asserted-by":"crossref","first-page":"413","DOI":"10.3892\/br.2016.737","article-title":"Effects of antiepileptic drugs on the serum folate and vitamin B12 in various epileptic patients","volume":"5","author":"Huang","year":"2016","journal-title":"Biomed. Rep."},{"issue":"3","key":"10.1016\/j.biopha.2021.112541_bib55","first-page":"244","article-title":"Oral contraceptives: effect of folate and vitamin B12 metabolism","volume":"126","author":"Shojania","year":"1982","journal-title":"Can. Med. Assoc. J."},{"issue":"5","key":"10.1016\/j.biopha.2021.112541_bib56","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/S1701-2163(15)30258-9","article-title":"Association between use of oral contraceptives and folate status: a systematic review and meta-analysis","volume":"37","author":"Shere","year":"2015","journal-title":"J. Obstet. Gynaecol. Can. JOGC J. D\u2019Obstet. Gynecol. Can. JOGC"},{"issue":"4","key":"10.1016\/j.biopha.2021.112541_bib57","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1002\/mnfr.201200077","article-title":"Folate, alcohol, and liver disease","volume":"57","author":"Medici","year":"2013","journal-title":"Mol. Nutr. Food Res."},{"issue":"7","key":"10.1016\/j.biopha.2021.112541_bib58","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med."},{"key":"10.1016\/j.biopha.2021.112541_bib59","unstructured":"National Health and Medical Research Council NHaMRC, NHMRC additional levels of evidence and grades for recommendations for developers of guidelines 2009. \u3008https:\/\/www.mja.com.au\/sites\/default\/files\/NHMRC.levels.of.evidence.2008\u201309.pdf\u3009."},{"issue":"4","key":"10.1016\/j.biopha.2021.112541_bib60","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1177\/0269881104047285","article-title":"The MTHFR C677T polymorphism is associated with depressive episodes in patients from Northern Ireland","volume":"18","author":"Kelly","year":"2004","journal-title":"J. Psychopharmacol."},{"issue":"6","key":"10.1016\/j.biopha.2021.112541_bib61","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1001\/archpsyc.60.6.618","article-title":"Folate, vitamin B12, homocysteine, and the MTHFR 677C->T polymorphism in anxiety and depression: the Hordaland Homocysteine Study","volume":"60","author":"Bjelland","year":"2003","journal-title":"Arch. Gen. Psychiatry"},{"issue":"1","key":"10.1016\/j.biopha.2021.112541_bib62","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12991-016-0103-5","article-title":"CT genotype of 5,10-methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism is protector factor of major depressive disorder in the Tunisian population: a case control study","volume":"15","author":"Sayadi","year":"2016","journal-title":"Ann. Gen. Psychiatry"},{"issue":"7","key":"10.1016\/j.biopha.2021.112541_bib63","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2013.60","article-title":"Interaction between the MTHFR C677T polymorphism and traumatic childhood events predicts depression","volume":"3","author":"Lok","year":"2013","journal-title":"Transl. Psychiatry"},{"issue":"1","key":"10.1016\/j.biopha.2021.112541_bib64","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/ajmg.b.32209","article-title":"Methylenetetrahydrofolate reductase (MTHFR) genetic variation and major depressive disorder prognosis: a five-year prospective cohort study of primary care attendees","volume":"165b","author":"Bousman","year":"2014","journal-title":"Am. J. Med. Genet. Part B Neuropsychiatr. Genet. Off. Publ. Int. Soc. Psychiatr. Genet."},{"issue":"3","key":"10.1016\/j.biopha.2021.112541_bib65","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.maturitas.2008.08.002","article-title":"Polymorphic variants of genes encoding MTHFR, MTR, and MTHFD1 and the risk of depression in postmenopausal women in Poland","volume":"61","author":"Slopien","year":"2008","journal-title":"Maturitas"},{"issue":"1","key":"10.1016\/j.biopha.2021.112541_bib66","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/ejcn.2011.136","article-title":"Folic acid supplementation during pregnancy may protect against depression 21 months after pregnancy, an effect modified by MTHFR C677T genotype","volume":"66","author":"Lewis","year":"2012","journal-title":"Eur. J. Clin. Nutr."},{"key":"10.1016\/j.biopha.2021.112541_bib67","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.biochi.2016.04.005","article-title":"The basis for folinic acid treatment in neuro-psychiatric disorders","volume":"126","author":"Ramaekers","year":"2016","journal-title":"Biochimie"},{"key":"10.1016\/j.biopha.2021.112541_bib68","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jad.2020.01.096","article-title":"Adjunctive folate for major mental disorders: a systematic review","volume":"267","author":"Zheng","year":"2020","journal-title":"J. Affect. Disord."},{"issue":"6","key":"10.1016\/j.biopha.2021.112541_bib69","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1192\/bjp.bp.114.145177","article-title":"B vitamins to enhance treatment response to antidepressants in middle-aged and older adults: results from the B-VITAGE randomised, double-blind, placebo-controlled trial","volume":"205","author":"Almeida","year":"2014","journal-title":"Br. J. Psychiatry"},{"issue":"12","key":"10.1016\/j.biopha.2021.112541_bib70","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1176\/appi.ajp.2012.11071114","article-title":"L-methylfolate as adjunctive therapy for SSRI-resistant major depression: results of two randomized, double-blind, parallel-sequential trials","volume":"169","author":"Papakostas","year":"2012","journal-title":"Am. J. Psychiatry"},{"issue":"8712","key":"10.1016\/j.biopha.2021.112541_bib71","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/0140-6736(90)91942-4","article-title":"Enhancement of recovery from psychiatric illness by methylfolate","volume":"336","author":"Godfrey","year":"1990","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.biopha.2021.112541_bib72","first-page":"19","article-title":"L-methylfolate Plus SSRI or SNRI from treatment initiation compared to SSRI or SNRI monotherapy in a major depressive episode","volume":"8","author":"Ginsberg","year":"2011","journal-title":"Innov. Clin. Neurosci."},{"issue":"5","key":"10.1016\/j.biopha.2021.112541_bib73","doi-asserted-by":"crossref","first-page":"654","DOI":"10.4088\/JCP.15m10181","article-title":"Long-term efficacy, safety, and tolerability of L-methylfolate calcium 15 mg as adjunctive therapy with selective serotonin reuptake inhibitors: a 12-month, open-label study following a placebo-controlled acute study","volume":"77","author":"Zajecka","year":"2016","journal-title":"J. Clin. Psychiatry"},{"issue":"7","key":"10.1016\/j.biopha.2021.112541_bib74","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1177\/070674371205700703","article-title":"Folates and S-adenosylmethionine for major depressive disorder","volume":"57","author":"Papakostas","year":"2012","journal-title":"Can. J. Psychiatry Rev. Can. Psychiatr."},{"issue":"3","key":"10.1016\/j.biopha.2021.112541_bib75","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1159\/000151527","article-title":"Effect of folic acid combined with fluoxetine in patients with major depression on plasma homocysteine and vitamin B12, and serotonin levels in lymphocytes","volume":"15","author":"Resler","year":"2008","journal-title":"Neuroimmunomodulation"},{"issue":"2","key":"10.1016\/j.biopha.2021.112541_bib76","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.jad.2013.02.029","article-title":"A randomized double-blind comparison of fluoxetine augmentation by high and low dosage folic acid in patients with depressive episodes","volume":"150","author":"Venkatasubramanian","year":"2013","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.biopha.2021.112541_bib77","doi-asserted-by":"crossref","first-page":"2","DOI":"10.5812\/ircmj.33243","article-title":"Acid folic supplementation in major depressive disorder treatment: a double-blind randomized clinical trial","volume":"19","author":"Sepehrmanesh","year":"2016","journal-title":"Iran. Red Crescent Med. J."},{"key":"10.1016\/j.biopha.2021.112541_bib78","first-page":"2","article-title":"Leucovorin as an antidepressant adjunct in elderly inpatients with treatment-resistant depression","volume":"23","author":"Saxena","year":"2021","journal-title":"Prim. Care Companion CNS Disord."},{"issue":"1","key":"10.1016\/j.biopha.2021.112541_bib79","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1192\/bjp.bp.109.075291","article-title":"Mental health literacy, folic acid and vitamin B12, and physical activity for the prevention of depression in older adults: randomised controlled trial","volume":"197","author":"Walker","year":"2010","journal-title":"Br. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.biopha.2021.112541_bib80","doi-asserted-by":"crossref","first-page":"194","DOI":"10.3945\/ajcn.110.007799","article-title":"Oral folic acid and vitamin B-12 supplementation to prevent cognitive decline in community-dwelling older adults with depressive symptoms--the Beyond Ageing Project: a randomized controlled trial","volume":"95","author":"Walker","year":"2012","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.biopha.2021.112541_bib81","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3390\/nu8110748","article-title":"Effects of two-year vitamin B12 and folic acid supplementation on depressive symptoms and quality of life in older adults with elevated homocysteine concentrations: additional results from the B-PROOF Study, an RCT","volume":"8","author":"de Koning","year":"2016","journal-title":"Nutrients"},{"issue":"1\u20132","key":"10.1016\/j.biopha.2021.112541_bib82","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jad.2010.07.029","article-title":"No clear potentiation of antidepressant medication effects by folic acid+vitamin B12 in a large community sample","volume":"130","author":"Christensen","year":"2011","journal-title":"J. Affect. Disord."},{"issue":"4","key":"10.1016\/j.biopha.2021.112541_bib83","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1192\/bjp.bp.114.148361","article-title":"Effect of long-term supplementation with folic acid and B vitamins on risk of depression in older women","volume":"206","author":"Okereke","year":"2015","journal-title":"Br. J. Psychiatry"},{"issue":"5","key":"10.1016\/j.biopha.2021.112541_bib84","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1093\/schbul\/sbt154","article-title":"Meta-analyses of blood homocysteine levels for gender and genetic association studies of the MTHFR C677T polymorphism in schizophrenia","volume":"40","author":"Nishi","year":"2014","journal-title":"Schizophr. Bull."},{"issue":"2","key":"10.1016\/j.biopha.2021.112541_bib85","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1002\/ajmg.b.31030","article-title":"Association between methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and age of onset in schizophrenia","volume":"153B","author":"Vares","year":"2010","journal-title":"Am. J. Med. Genet. Part B Neuropsychiatr. Genet. Off. Publ. Int. Soc. Psychiatr. Genet."},{"issue":"1","key":"10.1016\/j.biopha.2021.112541_bib86","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.biopsych.2006.12.017","article-title":"Contribution of methylenetetrahydrofolate reductase (MTHFR) polymorphisms to negative symptoms in schizophrenia","volume":"63","author":"Roffman","year":"2008","journal-title":"Biol. Psychiatry"},{"issue":"4","key":"10.1016\/j.biopha.2021.112541_bib87","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.ymgme.2014.10.002","article-title":"Folinic acid treatment for schizophrenia associated with folate receptor autoantibodies","volume":"113","author":"Ramaekers","year":"2014","journal-title":"Mol. Genet. Metab."},{"issue":"6","key":"10.1016\/j.biopha.2021.112541_bib88","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/dneu.21000","article-title":"Glutamate carboxypeptidase II and folate deficiencies result in reciprocal protection against cognitive and social deficits in mice: implications for neurodevelopmental disorders","volume":"72","author":"Schaevitz","year":"2012","journal-title":"Dev. Neurobiol."},{"issue":"11","key":"10.1016\/j.biopha.2021.112541_bib89","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1038\/mp.2012.137","article-title":"Molecular evidence of N-methyl-D-aspartate receptor hypofunction in schizophrenia","volume":"18","author":"Weickert","year":"2013","journal-title":"Mol. Psychiatry"},{"issue":"6","key":"10.1016\/j.biopha.2021.112541_bib90","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.neuron.2009.05.012","article-title":"Soluble oligomers of amyloid Beta protein facilitate hippocampal long-term depression by disrupting neuronal glutamate uptake","volume":"62","author":"Li","year":"2009","journal-title":"Neuron"},{"key":"10.1016\/j.biopha.2021.112541_bib91","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.fct.2013.09.015","article-title":"Dose-dependent folic acid and memantine treatments promote synergistic or additive protection against A\u03b2(25-35) peptide-induced apoptosis in SH-SY5Y cells mediated by mitochondria stress-associated death signals","volume":"62","author":"Chen","year":"2013","journal-title":"Food Chem. Toxicol. Int. J. Publ. Br. Ind. Biol. Res. Assoc."},{"issue":"4","key":"10.1016\/j.biopha.2021.112541_bib92","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1007\/s10517-007-0390-6","article-title":"Expression of NMDA receptors in multipotent stromal cells of human adipose tissue under conditions of retinoic acid-induced differentiation","volume":"144","author":"Kulikov","year":"2007","journal-title":"Bull. Exp. Biol. Med."},{"key":"10.1016\/j.biopha.2021.112541_bib93","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3390\/biom10081134","article-title":"Is memantine effective as an NMDA-receptor antagonist in adjunctive therapy for schizophrenia?","volume":"10","author":"Kikuchi","year":"2020","journal-title":"Biomolecules"},{"issue":"1","key":"10.1016\/j.biopha.2021.112541_bib94","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1017\/S0033291717001271","article-title":"Adjunctive memantine for schizophrenia: a meta-analysis of randomized, double-blind, placebo-controlled trials","volume":"48","author":"Zheng","year":"2018","journal-title":"Psychol. Med."},{"issue":"1\u20133","key":"10.1016\/j.biopha.2021.112541_bib95","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.schres.2010.12.006","article-title":"Folate supplementation in schizophrenia: a possible role for MTHFR genotype","volume":"127","author":"Hill","year":"2011","journal-title":"Schizophr. Res."},{"issue":"5","key":"10.1016\/j.biopha.2021.112541_bib96","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1001\/jamapsychiatry.2013.900","article-title":"Randomized multicenter investigation of folate plus vitamin B12 supplementation in schizophrenia","volume":"70","author":"Roffman","year":"2013","journal-title":"JAMA Psychiatry"},{"issue":"10","key":"10.1016\/j.biopha.2021.112541_bib97","doi-asserted-by":"crossref","first-page":"4229","DOI":"10.1111\/j.1582-4934.2008.00463.x","article-title":"One carbon metabolism disturbances and the C677T MTHFR gene polymorphism in children with autism spectrum disorders","volume":"13","author":"Pa\u015fca","year":"2009","journal-title":"J. Cell. Mol. Med."},{"issue":"8","key":"10.1016\/j.biopha.2021.112541_bib98","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1089\/gtmb.2012.0091","article-title":"Methylenetetrahydrofolate reductase polymorphisms C677T and risk of autism in the Chinese Han population","volume":"16","author":"Guo","year":"2012","journal-title":"Genet. Test. Mol. Biomark."},{"issue":"1","key":"10.1016\/j.biopha.2021.112541_bib99","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.psychres.2013.11.006","article-title":"MTHFR 1298A>C is a risk factor for autism spectrum disorder in the Korean population","volume":"215","author":"Park","year":"2014","journal-title":"Psychiatry Res."},{"issue":"4","key":"10.1016\/j.biopha.2021.112541_bib100","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1097\/EDE.0b013e31821d0e30","article-title":"Prenatal vitamins, one-carbon metabolism gene variants, and risk for autism","volume":"22","author":"Schmidt","year":"2011","journal-title":"Epidemiology"},{"issue":"3","key":"10.1016\/j.biopha.2021.112541_bib101","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/mp.2012.22","article-title":"Role of folate receptor autoantibodies in infantile autism","volume":"18","author":"Ramaekers","year":"2013","journal-title":"Mol. Psychiatry"},{"issue":"3","key":"10.1016\/j.biopha.2021.112541_bib102","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/mp.2011.175","article-title":"Cerebral folate receptor autoantibodies in autism spectrum disorder","volume":"18","author":"Frye","year":"2013","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.biopha.2021.112541_bib103","article-title":"Prenatal folic acid supplements and offspring\u2019s autism spectrum disorder: a meta-analysis and meta-regression","author":"Liu","year":"2021","journal-title":"J. Autism Dev. Disord."},{"key":"10.1016\/j.biopha.2021.112541_bib104","doi-asserted-by":"crossref","unstructured":"K.K. Brieger, K.M. Bakulski, C.L. Pearce, A. Baylin, J.F. Dou, J.I. Feinberg, et al., The association of prenatal vitamins and folic acid supplement intake with odds of autism spectrum disorder in a high-risk sibling cohort, the early autism risk longitudinal investigation (earli), J. Autism Dev. Disord. (2021).","DOI":"10.1007\/s10803-021-05110-9"},{"issue":"2","key":"10.1016\/j.biopha.2021.112541_bib105","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/mp.2016.168","article-title":"Folinic acid improves verbal communication in children with autism and language impairment: a randomized double-blind placebo-controlled trial","volume":"23","author":"Frye","year":"2018","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.biopha.2021.112541_bib106","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.biochi.2020.04.019","article-title":"Folinic acid improves the score of Autism in the EFFET placebo-controlled randomized trial","volume":"173","author":"Renard","year":"2020","journal-title":"Biochimie"},{"key":"10.1016\/j.biopha.2021.112541_bib107","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1007\/s10578-020-01072-8","article-title":"Folinic acid as adjunctive therapy in treatment of inappropriate speech in children with autism: a double-blind and placebo-controlled randomized trial","volume":"52","author":"Batebi","year":"2020","journal-title":"Child Psychiatry Hum. Dev."},{"key":"10.1016\/j.biopha.2021.112541_bib108","article-title":"Effectiveness of methylcobalamin and folinic Acid treatment on adaptive behavior in children with autistic disorder is related to glutathione redox status","volume":"2013","author":"Frye","year":"2013","journal-title":"Autism Res. Treat."},{"issue":"1","key":"10.1016\/j.biopha.2021.112541_bib109","doi-asserted-by":"crossref","first-page":"425","DOI":"10.3945\/ajcn.2008.26615","article-title":"Efficacy of methylcobalamin and folinic acid treatment on glutathione redox status in children with autism","volume":"89","author":"James","year":"2009","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.biopha.2021.112541_bib110","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3390\/nu8060337","article-title":"Efficacy of folic acid supplementation in autistic children participating in structured teaching: an open-label trial","volume":"8","author":"Sun","year":"2016","journal-title":"Nutrients"},{"issue":"8","key":"10.1016\/j.biopha.2021.112541_bib111","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1016\/j.bbi.2010.12.006","article-title":"Meta-analysis of MTHFR gene variants in schizophrenia, bipolar disorder and unipolar depressive disorder: evidence for a common genetic vulnerability?","volume":"25","author":"Peerbooms","year":"2011","journal-title":"Brain Behav. Immun."},{"issue":"3","key":"10.1016\/j.biopha.2021.112541_bib112","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.neulet.2006.02.055","article-title":"Association of 677C>T polymorphism of methylenetetrahydrofolate reductase (MTHFR) gene with bipolar disorder and schizophrenia","volume":"400","author":"Kempisty","year":"2006","journal-title":"Neurosci. Lett."},{"issue":"1","key":"10.1016\/j.biopha.2021.112541_bib113","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.neulet.2008.10.077","article-title":"C677T methylenetetrahydrofolate reductase gene polymorphisms in bipolar disorder: an association study in the Chinese population and a meta-analysis of genetic association studies","volume":"449","author":"Chen","year":"2009","journal-title":"Neurosci. Lett."},{"issue":"1","key":"10.1016\/j.biopha.2021.112541_bib114","first-page":"1","article-title":"C677T Methylenetetrahydrofolate reductase (MTHFR) gene polymorphism in schizophrenia and bipolar disorder: an association study in Iranian population","volume":"6","author":"Arzaghi","year":"2011","journal-title":"Iran. J. Psychiatry"},{"issue":"7","key":"10.1016\/j.biopha.2021.112541_bib115","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1002\/ajmg.b.31101","article-title":"The Bipolar Association Case-Control Study (BACCS) and meta-analysis: no association with the 5,10-Methylenetetrahydrofolate reductase gene and bipolar disorder","volume":"153B","author":"Cohen-Woods","year":"2010","journal-title":"Am. J. Med. Genet. Part B Neuropsychiatr. Genet. Off. Publ. Int. Soc. Psychiatr. Genet."},{"issue":"1","key":"10.1016\/j.biopha.2021.112541_bib116","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S2215-0366(15)00450-2","article-title":"Comparative evaluation of quetiapine plus lamotrigine combination versus quetiapine monotherapy (and folic acid versus placebo) in bipolar depression (CEQUEL): a 2 x 2 factorial randomised trial","volume":"3","author":"Geddes","year":"2016","journal-title":"Lancet Psychiatry"},{"issue":"6","key":"10.1016\/j.biopha.2021.112541_bib117","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.1600-0447.2009.01368.x","article-title":"Folic acid efficacy as an alternative drug added to sodium valproate in the treatment of acute phase of mania in bipolar disorder: a double-blind randomized controlled trial","volume":"120","author":"Behzadi","year":"2009","journal-title":"Acta Psychiatr. Scand."},{"issue":"1","key":"10.1016\/j.biopha.2021.112541_bib118","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1089\/gtmb.2011.0062","article-title":"Methylenetetrahydrofolate reductase gene polymorphisms in turkish children with attention-deficit\/hyperactivity disorder","volume":"16","author":"Ergul","year":"2011","journal-title":"Genet. Test. Mol. Biomark."},{"issue":"11","key":"10.1016\/j.biopha.2021.112541_bib119","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/nu12113394","article-title":"Multinutrients for the treatment of psychiatric symptoms in clinical samples: a systematic review and meta-analysis of randomized controlled trials","volume":"12","author":"Johnstone","year":"2020","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.biopha.2021.112541_bib120","first-page":"9","article-title":"Effects of folic acid on appetite in children with attention deficit hyperactivity disorder (ADHD) treated with methylphenidate: a randomized double-blind clinical trial","volume":"43","author":"Riahi","year":"2018","journal-title":"Iran. J. Med. Sci."},{"issue":"6 Pt 2","key":"10.1016\/j.biopha.2021.112541_bib121","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1111\/j.1753-4887.2004.tb00070.x","article-title":"Physiology of folate and vitamin B12 in health and disease","volume":"62","author":"Stover","year":"2004","journal-title":"Nutr. Rev."},{"issue":"19","key":"10.1016\/j.biopha.2021.112541_bib122","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1182\/blood-2016-10-569186","article-title":"Vitamin B12 deficiency from the perspective of a practicing hematologist","volume":"129","author":"Green","year":"2017","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.biopha.2021.112541_bib123","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1038\/sj.ejcn.1602254","article-title":"[6S]5-methyltetrahydrofolate or folic acid supplementation and absorption and initial elimination of folate in young and middle-aged adults","volume":"59","author":"de Meer","year":"2005","journal-title":"Eur. J. Clin. Nutr."},{"issue":"3","key":"10.1016\/j.biopha.2021.112541_bib124","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1515\/cclm-2012-0561","article-title":"Molecular mechanisms underlying the potentially adverse effects of folate","volume":"51","author":"Strickland","year":"2013","journal-title":"Clin. Chem. Lab. Med."},{"issue":"6","key":"10.1016\/j.biopha.2021.112541_bib125","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1111\/j.1471-4159.2007.05095.x","article-title":"Characterization of folate uptake by choroid plexus epithelial cells in a rat primary culture model","volume":"104","author":"Wollack","year":"2008","journal-title":"J. Neurochem."},{"issue":"11","key":"10.1016\/j.biopha.2021.112541_bib126","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.1093\/jn\/135.11.2703","article-title":"Nutritional epigenetics: impact of folate deficiency on DNA methylation and colon cancer susceptibility","volume":"135","author":"Kim","year":"2005","journal-title":"J. Nutr."},{"issue":"3","key":"10.1016\/j.biopha.2021.112541_bib127","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s13668-018-0237-y","article-title":"Folate and its impact on cancer risk","volume":"7","author":"Pieroth","year":"2018","journal-title":"Curr. Nutr. Rep."},{"issue":"5","key":"10.1016\/j.biopha.2021.112541_bib128","article-title":"Elevated homocysteine level and folate deficiency associated with increased overall risk of carcinogenesis: meta-analysis of 83 case-control studies involving 35,758 individuals","volume":"10","author":"Zhang","year":"2015","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.biopha.2021.112541_bib129","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0165-6147(00)01675-8","article-title":"Biological and clinical implications of the MTHFR C677T polymorphism","volume":"22","author":"Ueland","year":"2001","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.biopha.2021.112541_bib130","doi-asserted-by":"crossref","first-page":"4155","DOI":"10.2147\/CMAR.S176263","article-title":"MTHFR C677T and A1298C polymorphisms and lung cancer risk in a female Chinese population","volume":"10","author":"Tong","year":"2018","journal-title":"Cancer Manag. Res."},{"issue":"15","key":"10.1016\/j.biopha.2021.112541_bib131","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1002\/pros.21200","article-title":"Relationship between three polymorphisms of methylenetetrahydrofolate reductase (MTHFR C677T, A1298C, and G1793A) gene and risk of prostate cancer: a case-control study","volume":"70","author":"Safarinejad","year":"2010","journal-title":"Prostate"},{"key":"10.1016\/j.biopha.2021.112541_bib132","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.toxrep.2019.09.012","article-title":"Safety evaluation of calcium L-methylfolate","volume":"6","author":"Niederberger","year":"2019","journal-title":"Toxicol. Rep."},{"issue":"6","key":"10.1016\/j.biopha.2021.112541_bib133","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.nutres.2015.02.006","article-title":"Cyclic supplementation of 5-MTHF is effective for the correction of hyperhomocysteinemia","volume":"35","author":"Ambrosino","year":"2015","journal-title":"Nutr. Res."},{"issue":"1","key":"10.1016\/j.biopha.2021.112541_bib134","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1093\/ajcn\/84.1.156","article-title":"Red blood cell folate concentrations increase more after supplementation with [6 S]-5-methyltetrahydrofolate than with folic acid in women of childbearing age","volume":"84","author":"Lamers","year":"2006","journal-title":"Am. J. Clin. Nutr."},{"issue":"3","key":"10.1016\/j.biopha.2021.112541_bib135","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1093\/jn\/134.3.580","article-title":"The short-term bioavailabilities of [6S]-5-methyltetrahydrofolate and folic acid are equivalent in men","volume":"134","author":"Pentieva","year":"2004","journal-title":"J. Nutr."},{"issue":"6","key":"10.1016\/j.biopha.2021.112541_bib136","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1055\/s-2008-1065354","article-title":"Folate receptor autoimmunity and cerebral folate deficiency in low-functioning autism with neurological deficits","volume":"38","author":"Ramaekers","year":"2007","journal-title":"Neuropediatrics"},{"issue":"3","key":"10.1016\/j.biopha.2021.112541_bib137","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1113\/JP276887","article-title":"Blood-brain barrier permeability measured using dynamic contrast-enhanced magnetic resonance imaging: a validation study","volume":"597","author":"Varatharaj","year":"2019","journal-title":"J. Physiol."},{"issue":"7","key":"10.1016\/j.biopha.2021.112541_bib138","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1038\/jcbfm.2015.76","article-title":"Cerebrospinal fluid biomarkers of neurovascular dysfunction in mild dementia and Alzheimer\u2019s disease","volume":"35","author":"Sweeney","year":"2015","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"4","key":"10.1016\/j.biopha.2021.112541_bib139","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.bbi.2009.01.017","article-title":"Lipopolysaccharide alters the blood-brain barrier transport of amyloid beta protein: a mechanism for inflammation in the progression of Alzheimer\u2019s disease","volume":"23","author":"Jaeger","year":"2009","journal-title":"Brain Behav. Immun."},{"issue":"11","key":"10.1016\/j.biopha.2021.112541_bib140","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1002\/cncr.11409","article-title":"Serum S100beta: a noninvasive marker of blood-brain barrier function and brain lesions","volume":"97","author":"Kanner","year":"2003","journal-title":"Cancer"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332221013287?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332221013287?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T10:48:25Z","timestamp":1779965305000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332221013287"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":140,"alternative-id":["S0753332221013287"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2021.112541","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The potential use of folate and its derivatives in treating psychiatric disorders: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2021.112541","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"112541"}}